Effectiveness of eHealth Interventions for Adolescents and Young Adults With Congenital Heart Disease: Systematic Review - Takeaways - MDSpire

Effectiveness of eHealth Interventions for Adolescents and Young Adults With Congenital Heart Disease: Systematic Review

  • By

  • Brith Andresen

  • Mari Oma Ohnstad

  • Marie Hamilton Larsen

  • Simen A Steindal

  • Henrik Brun

  • Katrine Onshuus Eriksen

  • Kristin Hofsø

  • Unni Jenssen

  • Marte-Marie Wallander Karlsen

  • Monica Evelyn Kvande

  • Kari L Mariussen

  • Philip Moons

  • Clarisse Sifa Nsengi

  • Kristin J Skaarud

  • Karoline Skedsmo

  • Kari Sørensen

  • Benedicte S Strøm

  • Ina Thon Aamodt

  • July 8, 2026

  • 0 min

Share

  • 1

    Congenital heart disease (CHD) affects 0.8% to 1% of newborns, with varying severity from simple to complex conditions.

  • 2

    Approximately 30% of newborns with CHD present with multiple structural defects, categorized as complex CHD.

  • 3

    The transition from childhood to young adulthood (ages 10 to 29) is a critical phase for individuals with CHD.

  • 4

    Successful transition to adult care for adolescents with CHD relies on disease knowledge, self-management skills, and symptom recognition.

  • 5

    Parental overprotection may hinder autonomy in adolescents with CHD, highlighting the need for confidence-building during transitions.

Original Source(s)

Effectiveness of eHealth Interventions for Adolescents and Young Adults With Congenital Heart Disease: Systematic Review

  • by Brith Andresen, Mari Oma Ohnstad, Marie Hamilton Larsen, Simen A Steindal, Henrik Brun, Katrine Onshuus Eriksen, Kristin Hofsø, Unni Jenssen, Marte-Marie Wallander Karlsen, Monica Evelyn Kvande, Kari L Mariussen, Philip Moons, Clarisse Sifa Nsengi, Kristin J Skaarud, Karoline Skedsmo, Kari Sørensen, Benedicte S Strøm, Ina Thon Aamodt

  • July 8, 2026

Related Content

Developmental Systems Cardiology: A Longitudinal Adaptive Framework for Congenital Heart Disease

Multidimensional cardiac functional phenotyping beyond ejection fraction: a multimodality imaging framework for cardiovascular care

Atorvastatin-associated neurological adverse events: a disproportionality analysis with adjustment for confounding by indication